We use cookies for a better user experience. Read our Privacy Policy

I Agree

Nanotechnology Drug Delivery Market

Nanotechnology Drug Delivery Market (Technology: Nanocrystals, Nanoparticles, Liposomes, Micelles, Nanotubes, and Others; and Application: Neurology, Oncology, Cardiovascular/Physiology, Anti-inflammatory/Immunology, Anti-infective, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2021-2028

Nanotechnology Drug Delivery Market Outlook 2028

  • The global nanotechnology drug delivery market was valued at US$ 77.1 Bn in 2020
  • It is estimated to expand at a CAGR of 7.9% from 2021 to 2028
  • The global nanotechnology drug delivery market is expected to cross the value of US$ 142.8 Bn by the end of 2028

Analysts’ Viewpoint on Nanotechnology Drug Delivery Market Scenario

The global nanotechnology drug delivery market is expected to witness tremendous growth opportunities due to rising incidences of oncology and chronic disorders across the globe. Companies in the global nanotechnology drug delivery market are gaining lucrative revenue opportunities due to a large number of ongoing clinical trials, outsourcing services, research activities, and increase in healthcare investment by governments. However, high cost of medicines and stringent regulations associated with nanotechnology drug delivery are some of the factors expected to impact the growth of the global nanotechnology drug delivery market during the forecast period.

Rise in Awareness of Nanotechnology Drug Delivery System

The nanotechnology drug delivery market is significantly driven by factors such as increasing awareness among the people about nanotechnology, rapidly increasing incidences of chronic illnesses, technological advancement, and rising investment in nanotechnology by government in several developing countries. Due to rising demand for novel drug delivery, manufacturers are gaining lucrative growth opportunities in the global market. Nanotechnology drug delivery is an expanding area of the healthcare industry, and is witnessing increasing acceptance in medical and healthcare applications.

The nanotechnology drug delivery system is used in neurology, anti-infective, cardiovascular disorders, and others. The system also has an application in transporting drugs to the final location of therapeutic intervention within the body. The nanotechnology drug delivery market is witnessing rapid growth due to increase in R&D activities in nanotechnology to develop novel nano-medicine. Various organic and inorganic nanomaterials have been utilized for DDS applications. The term nano pharmaceuticals cover different nano-based DDS that can be used to encapsulate drugs for better targeting than with conventional drugs.

To know the scope of our report Get a Sample on Nanotechnology Drug Delivery Market

Expanding Pharmaceutical Drug Development Companies Globally

There is a flourishing growth of pharmaceutical companies across the globe. Rising investment in R&D activities in drug development and discovery is contributing to expansion of the nanotechnology drug delivery market. The global pharmaceutical industry has been developing compounds for over a century. Many of these never reached the market. The acceptance of new drug formulations is expensive and slow process. It takes so many years to obtain accreditation of new drug formulas with no guarantee of success. Antineoplastic agents are highly effective in cancer treatment. However, it leads to chronic side effects due to cytotoxic properties and lack of target specificity. Hence, pharmaceutical companies are developing innovative drug delivery systems in order to increase target specificity for the cytotoxic drugs that are already present in the market.

Get a glimpse of the in-depth analysis through our Report Brochure

Clinical Advantages of Nanotechnology in Drug Delivery

The global nanotechnology drug delivery market has been classified into nanocrystals, liposomes, micelles, nanoparticles, nanotubes, etc. There has been a major role of a technology in the delivery of medicine to measure the size of the particles in nanometer ranges. The rising acceptance of nanotechnology-based drug delivery systems for both doctors and patients is due to lower drug toxicity, more specific targeting, and reduced cost of treatment. Nowadays, several drug entities fail clinical trials, as the compound is incapable to reach the targeted site without exhibiting any side effects. The delivery of a compound to specific target site is the most important part of any treatment ranging from infections to cancer. The overall drug consumption and side effects can be reduced with the help of the nanotechnology drug delivery system.

The nanotechnology drug delivery system is used in the field of neurology, oncology, cardiovascular/physiology, anti-inflammatory/immunology, anti-infective, and others. Oncology is the largest segment of the global market and expected to witness lucrative growth potential in the upcoming years due to rising cancer cases across the globe.

Expanding operations in future? To get the perfect launch ask for a custom report

Booming North America Nanotechnology Drug Delivery Market

North America is expected to account for a major market share of the global nanotechnology drug delivery market. Some of the key factors responsible for the market growth are well-established healthcare infrastructure and increase in number of biopharmaceutical companies in the region. The increasing prevalence chronic diseases all over the world demand technologically advanced drug delivery systems. Asia Pacific and Latin America are other attractive markets, which are poised to rise due to the increasing healthcare spending and improving healthcare facilities. This is due to economic growth, rise in spending capacity, surge in prevalence of cancers, and improvement in healthcare infrastructure.

Nanotechnology Drug Delivery Market: Overview

  • The role of technology in the delivery of medicine assures revolutionary advances in measuring the size of the particles in nanometer ranges
  • One important and active application area of nanotechnology drug delivery systems (DDS) is to transport drugs to the final location of therapeutic intervention within the body. Various organic and inorganic nanomaterials have been utilized for DDS applications.
  • The term nano pharmaceuticals (nano drugs) cover different nano-based DDS that can be used to encapsulate drugs for better targeting than with conventional drugs
  • The most common nanomaterials utilized for DDS include nanocrystals, liposome, protein-conjugate, dendrimers, and nanoparticles

Developing Potential of Existing Pharmaceutical Drugs: Key Driver

  • The global pharmaceutical industry has been developing compounds for over a century. However, several of these never got to the market. Acceptance of new drug formulations is expensive and slow, taking up to 15 years to obtain accreditation of new drug formulas with no guarantee of success.
  • Antineoplastic agents are highly effective in cancer treatment; however, it leads to chronic side effects due to cytotoxic properties and lack of target specificity. Hence, pharmaceutical companies are developing innovative drug delivery systems to increase target specificity for the cytotoxic drugs that are already present in the market.
  • New drug delivery compounds are likely to extend the product and patent lifecycles of drugs, enabling the creation of new chemical entities (NCEs) via reformulation of existing and/or orphaned compounds, and subsequent creation of value for shareholders and consumers
  • Therefore, renewing the product lifecycle of existing drugs is expected to boost market growth during the forecast period

Clinical Advantages of Nanotechnology in Drug Delivery: Major Driver

  • Benefits of nanotechnology-based drug delivery systems for both doctors and patients are lower drug toxicity, more specific targeting, and reduced cost of treatment
  • Presently, several drug entities fail clinical trials because the compound is incapable to reach the targeted site without exhibiting any side effects. Delivery of a compound to specific target site is one of the most integral parts of any treatment ranging from infections to cancer.
  • The overall drug consumption and side effects can be lowered significantly using nanotechnology drug delivery. The highly selective approach reduces the side effects and cost as well.
  • These factors are likely to propel the global nanotechnology drug delivery market during the forecast period

Nanotechnology Drug Delivery Market Snapshot

Attribute

Detail

Market Size Value in 2020 (Base Year)

US$ 77.1 Bn

Market Forecast Value in 2028

US$ 142.8 Bn

Growth Rate (CAGR)

7.9 %

Forecast Period

2017–2028

Quantitative Units

US$ Mn for Value

Market Analysis

It includes cross segment analysis at regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, pricing analysis, and parent industry overview.

Format

Electronic (PDF)

Market Segmentation

  • Technology
    • Nanocrystals
    • Nanoparticles
      • Dendrimers
      • Gold Nanoparticles
      • Fullerenes
    • Liposomes
    • Micelles
    • Nanotubes
    • Others
  • Application
    • Neurology
    • Oncology
    • Cardiovascular/Physiology
    • Anti-inflammatory/Immunology
    • Anti-infective
    • Others (Hematology, Ophthalmology, etc.)

Regions Covered

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa

Countries Covered

  • U.S.
  • Canada
  • Germany
  • U.K.
  • France
  • Italy
  • Spain
  • Rest of Europe
  • China
  • India
  • Japan
  • Australia & New Zealand
  • Rest of Asia Pacific
  • Brazil
  • Mexico
  • Rest of Latin America
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Customization Scope

Available upon request

Pricing

Available upon request

Nanotechnology Drug Delivery Market – Segmentation

TMR’s study on the global nanotechnology drug delivery market includes information divided into three segments: technology, application, and region. Changing industry trends and other market dynamics associated with these segments of the global nanotechnology drug delivery market are discussed in detail.

Technology
  • Nanocrystals
  • Nanoparticles
    • Dendrimers
    • Gold Nanoparticles
    • Fullerenes
  • Liposomes
  • Micelles
  • Nanotubes
  • Others
Application
  • Neurology
  • Oncology
  • Cardiovascular / Physiology
  • Anti-Inflammatory / Immunology
  • Anti-Infective
  • Others (Hematology, Ophthalmology, etc.)
Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East & Africa
Nanotechnology Drug Delivery Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

Frequently Asked Questions

What is the total market worth of nanotechnology drug delivery market?

Nanotechnology drug delivery market is expected to cross the value of US$ 142.8 Bn by the end of 2028

What would be the CAGR of the nanotechnology drug delivery market during the forecast period?

Nanotechnology drug delivery market is estimated to expand at a CAGR of 7.9% from 2021 to 2028

What are the key factors driving the nanotechnology drug delivery market?

The nanotechnology drug delivery market is driven increasing awareness among the people about nanotechnology and rapidly increasing incidences of chronic illnesses

Which region is more attractive for vendors in the nanotechnology drug delivery market?

North America is more attractive for vendors in the nanotechnology drug delivery market

Who are the key players in the nanotechnology drug delivery market?

Key players in the global nanotechnology drug delivery market include AbbVie, Inc., Amgen, Inc., Celgene Corporation, Johnson & Johnson, Merck & Co., Inc.

1. Preface

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary: Global Nanotechnology Drug Delivery Market

4. Market Overview

    4.1. Introduction

        4.1.1. Technology Definition

        4.1.2. Industry Evolution / Developments

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Nanotechnology Drug Delivery Market Analysis and Forecast, 2017–2028

        4.4.1. Market Revenue Projections (US$ Mn)

        4.4.2. Market Volume/Unit Shipments Projections

    4.5. Porter’s Five Force Analysis

5. Key Insights

    5.1. Technological Advancements

    5.2. Pricing Analysis

    5.3. Key Industry Events (mergers, acquisitions, partnerships, etc.)

    5.4. Covid-19 Impact Analysis

6. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Technology

    6.1. Introduction & Definition

    6.2. Key Findings / Developments

    6.3. Market Value & Volume Forecast, by Technology, 2017–2028

        6.3.1. Nanocrystals

        6.3.2. Nanoparticles

            6.3.2.1. Dendrimers

            6.3.2.2. Gold Nanoparticles

            6.3.2.3. Fullerenes

            6.3.2.4. Others

        6.3.3. Liposomes

        6.3.4. Micelles

        6.3.5. Nanotubes

        6.3.6. Others

    6.4. Market Attractiveness Analysis, by Technology

7. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Application

    7.1. Introduction & Definition

    7.2. Key Findings / Developments

    7.3. Market Value & Volume Forecast, by Application, 2017–2028

        7.3.1. Neurology

        7.3.2. Oncology

        7.3.3. Cardiovascular/Physiology

        7.3.4. Anti-inflammatory/Immunology

        7.3.5. Anti-infective

        7.3.6. Others (hematology, ophthalmology, etc.)

    7.4. Market Attractiveness Analysis, by Application

8. Global Nanotechnology Drug Delivery Market Analysis and Forecast, by Region

    8.1. Key Findings

    8.2. Market Value & Volume Forecast, by Region

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa

    8.3. Market Attractiveness Analysis, by Country/Region

9. North America Nanotechnology Drug Delivery Market Analysis and Forecast

    9.1. Introduction

        9.1.1. Key Findings

    9.2. Market Value & Volume Forecast, by Technology, 2017–2028

        9.2.1. Nanocrystals

        9.2.2. Nanoparticles

            9.2.2.1. Dendrimers

            9.2.2.2. Gold Nanoparticles

            9.2.2.3. Fullerenes

            9.2.2.4. Others

        9.2.3. Liposomes

        9.2.4. Micelles

        9.2.5. Nanotubes

        9.2.6. Others

    9.3. Market Value & Volume Forecast, by Application, 2017–2028

        9.3.1. Neurology

        9.3.2. Oncology

        9.3.3. Cardiovascular/Physiology

        9.3.4. Anti-inflammatory/Immunology

        9.3.5. Anti-infective

        9.3.6. Others (hematology, ophthalmology, etc.)

    9.4. Market Value & Volume Forecast, by Country, 2017–2028

        9.4.1. U.S.

        9.4.2. Canada

    9.5. Market Attractiveness Analysis

        9.5.1. By Technology

        9.5.2. By Application

        9.5.3. By Country

10. Europe Nanotechnology Drug Delivery Market Analysis and Forecast

    10.1. Introduction

        10.1.1. Key Findings

    10.2. Market Value & Volume Forecast, by Technology, 2017–2028

        10.2.1. Nanocrystals

        10.2.2. Nanoparticles

            10.2.2.1. Dendrimers

            10.2.2.2. Gold Nanoparticles

            10.2.2.3. Fullerenes

            10.2.2.4. Others

        10.2.3. Liposomes

        10.2.4. Micelles

        10.2.5. Nanotubes

        10.2.6. Others

    10.3. Market Value & Volume Forecast, by Application, 2017–2028

        10.3.1. Neurology

        10.3.2. Oncology

        10.3.3. Cardiovascular/Physiology

        10.3.4. Anti-inflammatory/Immunology

        10.3.5. Anti-infective

        10.3.6. Others (hematology, ophthalmology, etc.)

    10.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy

        10.4.6. Rest of Europe

    10.5. Market Attractiveness Analysis

        10.5.1. By Technology

        10.5.2. By Application

        10.5.3. By Country/Sub-region

11. Asia Pacific Nanotechnology Drug Delivery Market Analysis and Forecast

    11.1. Introduction

        11.1.1. Key Findings

    11.2. Market Value & Volume Forecast, by Technology, 2017–2028

        11.2.1. Nanocrystals

        11.2.2. Nanoparticles

            11.2.2.1. Dendrimers

            11.2.2.2. Gold Nanoparticles

            11.2.2.3. Fullerenes

            11.2.2.4. Others

        11.2.3. Liposomes

        11.2.4. Micelles

        11.2.5. Nanotubes

        11.2.6. Others

    11.3. Market Value & Volume Forecast, by Application, 2017–2028

        11.3.1. Neurology

        11.3.2. Oncology

        11.3.3. Cardiovascular/Physiology

        11.3.4. Anti-inflammatory/Immunology

        11.3.5. Anti-infective

        11.3.6. Others (hematology, ophthalmology, etc.)

    11.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        11.4.1. China

        11.4.2. Japan

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Market Attractiveness Analysis

        11.5.1. By Technology

        11.5.2. By Application

        11.5.3. By Country/Sub-region

12. Latin America Nanotechnology Drug Delivery Market Analysis and Forecast

    12.1. Introduction

        12.1.1. Key Findings

    12.2. Market Value & Volume Forecast, by Technology, 2017–2028

        12.2.1. Nanocrystals

        12.2.2. Nanoparticles

            12.2.2.1. Dendrimers

            12.2.2.2. Gold Nanoparticles

            12.2.2.3. Fullerenes

            12.2.2.4. Others

        12.2.3. Liposomes

        12.2.4. Micelles

        12.2.5. Nanotubes

        12.2.6. Others

    12.3. Market Value & Volume Forecast, by Application, 2017–2028

        12.3.1. Neurology

        12.3.2. Oncology

        12.3.3. Cardiovascular/Physiology

        12.3.4. Anti-inflammatory/Immunology

        12.3.5. Anti-infective

        12.3.6. Others (hematology, ophthalmology, etc.)

    12.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Market Attractiveness Analysis

        12.5.1. By Technology

        12.5.2. By Application

        12.5.3. By Country/Sub-region

13. Middle East & Africa Nanotechnology Drug Delivery Market Analysis and Forecast

    13.1. Introduction

        13.1.1. Key Findings

    13.2. Market Value & Volume Forecast, by Technology, 2017–2028

        13.2.1. Nanocrystals

        13.2.2. Nanoparticles

            13.2.2.1. Dendrimers

            13.2.2.2. Gold Nanoparticles

            13.2.2.3. Fullerenes

            13.2.2.4. Others

        13.2.3. Liposomes

        13.2.4. Micelles

        13.2.5. Nanotubes

        13.2.6. Others

    13.3. Market Value & Volume Forecast, by Application, 2017–2028

        13.3.1. Neurology

        13.3.2. Oncology

        13.3.3. Cardiovascular/Physiology

        13.3.4. Anti-inflammatory/Immunology

        13.3.5. Anti-infective

        13.3.6. Others (hematology, ophthalmology, etc.)

    13.4. Market Value & Volume Forecast, by Country/Sub-region, 2017–2028

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Market Attractiveness Analysis

        13.5.1. By Technology

        13.5.2. By Application

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (by tier and size of companies)

    14.2. Market Share Analysis, by Company, 2020

    14.3. Market Footprint Analysis

        14.3.1. By Region

        14.3.2. By Technology

        14.3.3. By Application

    14.4. Competitive Business Strategies

    14.5. Company Profiles

        14.5.1. AbbVie, Inc.

            14.5.1.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.1.2. Product Portfolio

            14.5.1.3. SWOT Analysis

            14.5.1.4. Strategic Overview

        14.5.2. Amgen, Inc.

            14.5.2.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.2.2. Product Portfolio

            14.5.2.3. SWOT Analysis

            14.5.2.4. Strategic Overview

        14.5.3. Celgene Corporation

            14.5.3.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.3.2. Product Portfolio

            14.5.3.3. SWOT Analysis

            14.5.3.4. Strategic Overview

        14.5.4. Johnson & Johnson

            14.5.4.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.4.2. Product Portfolio

            14.5.4.3. SWOT Analysis

            14.5.4.4. Strategic Overview

        14.5.5. Merck & Co., Inc.

            14.5.5.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.5.2. Product Portfolio

            14.5.5.3. SWOT Analysis

            14.5.5.4. Strategic Overview

        14.5.6. Perrigo Company plc

            14.5.6.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.6.2. Product Portfolio

            14.5.6.3. SWOT Analysis

            14.5.6.4. Strategic Overview

        14.5.7. Pfizer, Inc.

            14.5.7.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.7.2. Product Portfolio

            14.5.7.3. SWOT Analysis

            14.5.7.4. Strategic Overview

        14.5.8. Teva Pharmaceutical Industries Ltd.

            14.5.8.1. Company Overview (HQ, Business Segments, Employee Strength)

            14.5.8.2. Product Portfolio

            14.5.8.3. SWOT Analysis

            14.5.8.4. Strategic Overview

        14.5.9. Other players

List of Table

Table 01: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

Table 02: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

Table 03: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Region, 2021–2028

Table 04: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

Table 05: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country, 2021–2028

Table 06: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

Table 07: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

Table 08: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

Table 09: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2021–2028

Table 10: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2021–2028

Table 11: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

Table 12: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2021–2028

Table 13: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2017–2028

Table 14: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

Table 15: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017–2028

Table 16: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Technology, 2017–2028

Table 17: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Application, 2021–2028

Table 18: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, by Country/Sub-region, 2017–2028

List of Figures

Figure 01: Global Nanotechnology Drug Delivery Market Snapshot

Figure 02: Global Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%), 2017–2028

Figure 03: Market Value Share, by Technology, 2020

Figure 04: Market Value Share, by Application, 2020

Figure 05: Market Value Share, by Region, 2020

Figure 06: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

Figure 07: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanocrystals, 2017–2028 

Figure 08: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanoparticles, 2017–2028

Figure 09: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Liposomes, 2017–2028

Figure 10: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Micelles, 2017–2028

Figure 11: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Nanotubes, 2017–2028

Figure 12: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

Figure 13: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Neurology, 2017–2028 

Figure 14: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Oncology, 2017–2028

Figure 15: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Cardiovascular/Physiology, 2017–2028

Figure 16: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Anti-inflammatory/Immunology, 2017–2028

Figure 17: Global Nanotechnology Drug Delivery Market Revenue (US$ Bn) and Y-o-Y Growth (%), by Anti-infective, 2017–2028

Figure 18: Global Nanotechnology Drug Delivery Market Value Share Analysis, by Region, 2020 and 2028

Figure 19: Global Nanotechnology Drug Delivery Market Attractiveness Analysis, by Region

Figure 20: North America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2021–2028

Figure 21: North America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country, 2020 and 2018

Figure 22: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

Figure 23: North America Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

Figure 24: Europe Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2021–2028

Figure 25: Europe Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region

Figure 26: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

Figure 27: Europe Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

Figure 28: Asia Pacific Nanotechnology Drug Delivery Market Size (US$ Bn) and Y-o-Y Growth (%) Forecast, 2017– 2027

Figure 29: Asia Pacific Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 30: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

Figure 31: Asia Pacific Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

Figure 32: Latin America Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast and Y-o-Y Growth (%) Projection, 2017–2028

Figure 33: Latin America Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region, 2021–2028

Figure 34: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

Figure 35: Latin America Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

Figure 36: Middle East & Africa Nanotechnology Drug Delivery Market Size (US$ Bn) Forecast, 2017–2028

Figure 37: Middle East & Africa Nanotechnology Drug Delivery Market Attractiveness Analysis, by Country/Sub-region

Figure 38: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Technology, 2020 and 2028

Figure 39: Middle East & Africa Nanotechnology Drug Delivery Market Value Share Analysis, by Application, 2020 and 2028

Figure 40: Global Nanotechnology Drug Delivery Market Share Analysis, by Company (2020)

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

194

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved